Keyword: Insys Therapeutics
Beleaguered Insys faces yet another legal challenge with Anthem's decision to take the opioid drugmaker to court.
Two former Insys saleswomen have copped to charges that they took part in a kickback scheme designed to push sales of pain drug Subsys.
Embroiled in a web of allegations and investigations over Subsys marketing, Insys Therapeutics faces a new lawsuit.
A top Senate Democrat is throwing the weight of her office behind efforts to dig into opioid marketing practices.
Inksys Therapeutics expands a Texas manufacturing site despite legal turmoil from an indictment claiming its former CEO bribed doctors to prescribe Subsys.
With its billionaire founder headed for the exit—and Subsys marketing probes still going—troubled Insys Therapeutics is forced to step up its hunt for a new CEO.
Insys Therapeutics execs operated a “nationwide conspiracy” to boost scripts of Subsys, federal prosecutors allege in an indictment that details how not to comply with sales rules.
After arresting a series of lower-level workers, the feds on Thursday hauled in former CEO Michael Babich and a group of other execs.
For pharma and a former Warner Chilcott manager, it could have been much worse. Ex-district manager Landon Eckles was sentenced to 1 year of probation and a fine of $10,000 for violating health privacy laws by filling out prior authorization forms for doctors who prescribed the Warner bone med Atelvia.
Legal woes continue to pile up for former Insys Therapeutics employees. Officers arrested another ex-sales manager, who'll face new kickbacks charges stemming from hundreds of “sham” speaking programs designed to promote the powerful pain drug fentanyl.